Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction

Ko Bando, Gordon K. Danielson, Hartzell V Schaff, Douglas D. Mair, Paul R. Julsrud, Francisco J. Puga

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

To determine late patient outcome and homograft durability, we reviewed 326 patients who received aortic ( n = 230) or pulmonary ( n = 118) cryopreserved homografts for right ventricular outflow reconstruction between January 1985 and October 1993. Patient survival, including operative mortality, 5 years after the operation was similar between the two groups (ulmonary homograft 86%, aortic homograft 80%; p = not significant by log-rank test). However, 5-year freedom from homograft failure was significantly better for pulmonary homografts (94% versus 70%), p < 0.01 by log-rank test). Late calcification was evaluated by chest roentgenography and echocardiography. Overall, 20% of aortic homografts became moderately or severely calcified compared with 4% of pulmonary homografts ( p < 0.001). Twenty-six percent of aortic homografts in children 4 years old or younger had moderate or severe obstruction associated with calcification, whereas only 11% of aortic homografts in patients over 4 years of age had calcific obstruction ( p < 0.01). No late deaths among patients receiving pulmonary homografts were related to graft failure; two late deaths in the aortic homograft group were homograft related. Risk factors for patient mortality and homograft failure (defined as either need for homograft replacement because of homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for both mortality ( p < 0.01) and homograft failure ( p = 0.03) in aortic homograft recipients but not in pulmonary homograft recipients. These results indicate that both aortic and pulmonary homografts provided excellent intermediate-term patient survival after right ventricular outflow tract reconstruction, but pulmonary homografts are more durable than aortic homografts with less calcification and obstruction, especially among children 4 years old or younger. (J T HORAC C ARDIOVASC SURG 1995; 109: 509-18).

Original languageEnglish (US)
Pages (from-to)509-518
Number of pages10
JournalThe Journal of Thoracic and Cardiovascular Surgery
Volume109
Issue number3
DOIs
StatePublished - 1995

Fingerprint

Allografts
Lung
Mortality
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. / Bando, Ko; Danielson, Gordon K.; Schaff, Hartzell V; Mair, Douglas D.; Julsrud, Paul R.; Puga, Francisco J.

In: The Journal of Thoracic and Cardiovascular Surgery, Vol. 109, No. 3, 1995, p. 509-518.

Research output: Contribution to journalArticle

Bando, Ko ; Danielson, Gordon K. ; Schaff, Hartzell V ; Mair, Douglas D. ; Julsrud, Paul R. ; Puga, Francisco J. / Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. In: The Journal of Thoracic and Cardiovascular Surgery. 1995 ; Vol. 109, No. 3. pp. 509-518.
@article{68e1c1c8aa36423586b6625d4aea37a8,
title = "Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction",
abstract = "To determine late patient outcome and homograft durability, we reviewed 326 patients who received aortic ( n = 230) or pulmonary ( n = 118) cryopreserved homografts for right ventricular outflow reconstruction between January 1985 and October 1993. Patient survival, including operative mortality, 5 years after the operation was similar between the two groups (ulmonary homograft 86{\%}, aortic homograft 80{\%}; p = not significant by log-rank test). However, 5-year freedom from homograft failure was significantly better for pulmonary homografts (94{\%} versus 70{\%}), p < 0.01 by log-rank test). Late calcification was evaluated by chest roentgenography and echocardiography. Overall, 20{\%} of aortic homografts became moderately or severely calcified compared with 4{\%} of pulmonary homografts ( p < 0.001). Twenty-six percent of aortic homografts in children 4 years old or younger had moderate or severe obstruction associated with calcification, whereas only 11{\%} of aortic homografts in patients over 4 years of age had calcific obstruction ( p < 0.01). No late deaths among patients receiving pulmonary homografts were related to graft failure; two late deaths in the aortic homograft group were homograft related. Risk factors for patient mortality and homograft failure (defined as either need for homograft replacement because of homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for both mortality ( p < 0.01) and homograft failure ( p = 0.03) in aortic homograft recipients but not in pulmonary homograft recipients. These results indicate that both aortic and pulmonary homografts provided excellent intermediate-term patient survival after right ventricular outflow tract reconstruction, but pulmonary homografts are more durable than aortic homografts with less calcification and obstruction, especially among children 4 years old or younger. (J T HORAC C ARDIOVASC SURG 1995; 109: 509-18).",
author = "Ko Bando and Danielson, {Gordon K.} and Schaff, {Hartzell V} and Mair, {Douglas D.} and Julsrud, {Paul R.} and Puga, {Francisco J.}",
year = "1995",
doi = "10.1016/S0022-5223(95)70282-2",
language = "English (US)",
volume = "109",
pages = "509--518",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction

AU - Bando, Ko

AU - Danielson, Gordon K.

AU - Schaff, Hartzell V

AU - Mair, Douglas D.

AU - Julsrud, Paul R.

AU - Puga, Francisco J.

PY - 1995

Y1 - 1995

N2 - To determine late patient outcome and homograft durability, we reviewed 326 patients who received aortic ( n = 230) or pulmonary ( n = 118) cryopreserved homografts for right ventricular outflow reconstruction between January 1985 and October 1993. Patient survival, including operative mortality, 5 years after the operation was similar between the two groups (ulmonary homograft 86%, aortic homograft 80%; p = not significant by log-rank test). However, 5-year freedom from homograft failure was significantly better for pulmonary homografts (94% versus 70%), p < 0.01 by log-rank test). Late calcification was evaluated by chest roentgenography and echocardiography. Overall, 20% of aortic homografts became moderately or severely calcified compared with 4% of pulmonary homografts ( p < 0.001). Twenty-six percent of aortic homografts in children 4 years old or younger had moderate or severe obstruction associated with calcification, whereas only 11% of aortic homografts in patients over 4 years of age had calcific obstruction ( p < 0.01). No late deaths among patients receiving pulmonary homografts were related to graft failure; two late deaths in the aortic homograft group were homograft related. Risk factors for patient mortality and homograft failure (defined as either need for homograft replacement because of homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for both mortality ( p < 0.01) and homograft failure ( p = 0.03) in aortic homograft recipients but not in pulmonary homograft recipients. These results indicate that both aortic and pulmonary homografts provided excellent intermediate-term patient survival after right ventricular outflow tract reconstruction, but pulmonary homografts are more durable than aortic homografts with less calcification and obstruction, especially among children 4 years old or younger. (J T HORAC C ARDIOVASC SURG 1995; 109: 509-18).

AB - To determine late patient outcome and homograft durability, we reviewed 326 patients who received aortic ( n = 230) or pulmonary ( n = 118) cryopreserved homografts for right ventricular outflow reconstruction between January 1985 and October 1993. Patient survival, including operative mortality, 5 years after the operation was similar between the two groups (ulmonary homograft 86%, aortic homograft 80%; p = not significant by log-rank test). However, 5-year freedom from homograft failure was significantly better for pulmonary homografts (94% versus 70%), p < 0.01 by log-rank test). Late calcification was evaluated by chest roentgenography and echocardiography. Overall, 20% of aortic homografts became moderately or severely calcified compared with 4% of pulmonary homografts ( p < 0.001). Twenty-six percent of aortic homografts in children 4 years old or younger had moderate or severe obstruction associated with calcification, whereas only 11% of aortic homografts in patients over 4 years of age had calcific obstruction ( p < 0.01). No late deaths among patients receiving pulmonary homografts were related to graft failure; two late deaths in the aortic homograft group were homograft related. Risk factors for patient mortality and homograft failure (defined as either need for homograft replacement because of homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for homograft failure ( p < 0.0001), but type of homograft was not correlated with patient mortality. Age 4 years or younger was a significant risk factor for both mortality ( p < 0.01) and homograft failure ( p = 0.03) in aortic homograft recipients but not in pulmonary homograft recipients. These results indicate that both aortic and pulmonary homografts provided excellent intermediate-term patient survival after right ventricular outflow tract reconstruction, but pulmonary homografts are more durable than aortic homografts with less calcification and obstruction, especially among children 4 years old or younger. (J T HORAC C ARDIOVASC SURG 1995; 109: 509-18).

UR - http://www.scopus.com/inward/record.url?scp=0028957701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028957701&partnerID=8YFLogxK

U2 - 10.1016/S0022-5223(95)70282-2

DO - 10.1016/S0022-5223(95)70282-2

M3 - Article

C2 - 7877312

AN - SCOPUS:0028957701

VL - 109

SP - 509

EP - 518

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 3

ER -